美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA211675"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0074-2306-70 0074-2306 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20190816 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 15 mg/1 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70)
0074-2310-20 0074-2310 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20190816 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 30 mg/1 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20)
0074-2310-30 0074-2310 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20190816 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 30 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30)
0074-2306-30 0074-2306 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20190816 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 15 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30)
0074-1043-28 0074-1043 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20220316 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 45 mg/1 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28)
0074-1043-14 0074-1043 HUMAN PRESCRIPTION DRUG Rinvoq Upadacitinib TABLET, EXTENDED RELEASE ORAL 20220316 N/A NDA NDA211675 AbbVie Inc. UPADACITINIB 45 mg/1 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase